Insider · CIK 0001959750
Bilal Arif
officer
Files at SRPT (Sarepta Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | SRPT Sarepta Therapeutics, Inc. | AGrant or award Performance Stock Unitsderivative | +6,250 | $0.00 | $0 | 6,250 | Aug 6, 2025 |
| Mar 10, 2025 | SRPT Sarepta Therapeutics, Inc. | FTax withholding Common Stock | -523 | $100.13 | $52k | 24,224 | Mar 11, 2025 |
| Mar 10, 2025 | SRPT Sarepta Therapeutics, Inc. | AGrant or award Common Stock | +8,276 | - | - | 32,500 | Mar 11, 2025 |
| Mar 10, 2025 | SRPT Sarepta Therapeutics, Inc. | AGrant or award Stock Options (right to buy)derivative | +16,644 | $0.00 | $0 | 16,644 | Mar 11, 2025 |
| Mar 6, 2025 | SRPT Sarepta Therapeutics, Inc. | MOption exercise Common Stock | +17,500 | - | - | 33,782 | Mar 10, 2025 |
| Mar 7, 2025 | SRPT Sarepta Therapeutics, Inc. | FTax withholding Common Stock | -508 | $103.70 | $53k | 33,274 | Mar 10, 2025 |
| Mar 7, 2025 | SRPT Sarepta Therapeutics, Inc. | FTax withholding Common Stock | -8,527 | $103.70 | $884k | 24,747 | Mar 10, 2025 |
| Mar 6, 2025 | SRPT Sarepta Therapeutics, Inc. | MOption exercise Performance Stock Unitsderivative | -17,500 | $0.00 | $0 | 0 | Mar 10, 2025 |
| Mar 4, 2025 | SRPT Sarepta Therapeutics, Inc. | FTax withholding Common Stock | -281 | $101.34 | $28k | 16,515 | Mar 6, 2025 |
| Mar 4, 2025 | SRPT Sarepta Therapeutics, Inc. | FTax withholding Common Stock | -233 | $101.34 | $24k | 16,282 | Mar 6, 2025 |
| Mar 3, 2025 | SRPT Sarepta Therapeutics, Inc. | FTax withholding Common Stock | -719 | $103.77 | $75k | 16,796 | Mar 4, 2025 |
| Feb 11, 2025 | SRPT Sarepta Therapeutics, Inc. | AGrant or award Performance Restricted Stock Unitsderivative | +3,500 | $0.00 | $0 | 17,500 | Feb 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.